Inflammation and Cardiovascular Risk: A Systematic Review of High-Sensitivity CRP as a Prognostic Indicator

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Inflammation Biology

Background:

• Type 2 diabetes is a major risk factor for cardiovascular disease (CVD).
• Inflammation plays a critical role in the pathogenesis of diabetic complications.
• Current risk prediction models may not fully capture residual cardiovascular risk.

Purpose of the Study:

• To systematically review the prognostic value of high-sensitivity C-reactive protein (hs-CRP) in predicting cardiovascular outcomes in individuals with type 2 diabetes.
• To assess whether hs-CRP provides incremental predictive information beyond traditional risk factors.
• To explore the potential role of hs-CRP in risk stratification and guiding therapeutic strategies.

Main Methods:

• Systematic review of prospective cohort studies.
• Inclusion of studies evaluating hs-CRP and cardiovascular outcomes in type 2 diabetes populations.
• Analysis of prognostic performance, including adjustment for conventional risk factors.

Main Results:

• Elevated hs-CRP levels consistently predict major adverse cardiovascular events and vascular mortality in type 2 diabetes.
• hs-CRP retains independent prognostic value, even after accounting for glycemic control, lipids, and blood pressure.
• hs-CRP may reflect systemic inflammation and impaired recovery, contributing to residual cardiovascular risk.

Conclusions:

• hs-CRP is a clinically significant biomarker for cardiovascular risk in type 2 diabetes.
• Inflammation, as indicated by hs-CRP, is an independent and potentially modifiable determinant of cardiovascular outcomes.
• Integrating hs-CRP into risk assessment may improve personalized prevention strategies for diabetic patients.